首页 | 本学科首页   官方微博 | 高级检索  
     


Antifibrillatory Effect of Some β-Adrenergic Receptor Blocking Agents Determined by a New Test Procedure in Mice
Authors:Keld Hermansen
Abstract:Mice which were exposed to high concentrations of methylchloroform (1,1,1, trichloroethane) vapour died in cardiac fibrillation. Pretreatment 30 min. before the administration of methylchloroform gave the following antifibrillatory ED50's expressed in mg/kg intraperitoneally: β-adrenergic blocking agents: Propranolol: 1.7; (+)-propranolol: 45; (-)-propranolol 0.6; 1-(isopropylamino)-3-(o-phenoxyphenoxy)-2-propanol, HC1 (Ph QA 33): 6.5; 1-(isopropylamino)-3-(o-allylphenoxy)-2-propanol, HC1 (H 56/28 = aptin®): 19; 4-(2-isopropylamino-1-hydroxyethyl) methane sulphonanilide, HC1 (MJ 1999): 24; 2-(isopropylamino)-1-(p-nitrophenyl) ethanol, HC1 (INPEA): 50; dichloroisoprenaline (DCI): no effect; α-adrenergic blocking compounds: chlorpromazine: > 50; phenoxybenzamine, HC1 (dibenzyline®): no effect, phentolamine (regitin®): > 100. None of some commonly used antiarrhythmics: antazoline, HC1; lidocaine, HC1; phenytoin; procainamide, HC1 (pronestyl®) or quinidine sulphate had any effect. The most favourable therapeutic index (LD50/ED50) was found for (-)-propranolol ~ 200. The method appears particularly suitable for evaluation of compounds with antagonistic action on cardiac β-receptors and in this respect appears to be highly sensitive.
Keywords:Mice  ventricular fibrillation  hydrocarbons halogenated  sympatholytics
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号